Unmissable Webinars on Organoids, Interviews, Case Studies and Cutting-Edge Research!
From Crown Bioscience & World Organoid Research Day+ 2024
Watch Now and Win the chance of a free pair of tickets to
World Organoid Research Day+ in 2024!
Watch November's webinar now!
Cancer Organoid Screening: Bridging Reproducibility and Clinical Relevance in Drug Discovery
Don't miss the opportunity to view a transformative talk by Liza Wijler, an authority in the field of organoid drug discovery. In this crucial discussion on Pan-cancer 'Assay-ready' Organoid Drug Screening, you will delve deep into the innovations that are setting new standards for preclinical anticancer drug screening. You'll learn about:
- Revolutionary Organoid Models: Learn about Patient-Derived Organoids (PDOs) and Patient-Derived Xenograft–Derived Organoids (PDXOs), which are superior 3D tumor models that more accurately simulate human cancer conditions, thereby improving the translatability of preclinical data.
- High Throughput Drug Screening (HTS): Gain insights into how these organoid models are uniquely suited for high-throughput drug screening, an essential phase in early drug discovery. They offer benefits such as genetic stability and high clinical predictivity.
- Case Study Insights: The talk will feature a detailed case study comparing an Assay-Ready (AR) organoid platform to traditional models. Learn how this revolutionary platform significantly cuts down timelines and costs.
- Practical Applications: Discover how these advanced organoid models can be leveraged for large-scale studies, thus allowing for quicker decision-making about lead compounds, patient stratification, and more.
September
September
September
Matched Model Pairs and Patient-Derived Xenografts
and Organoids Biobanks.
October
September
September
Functional Screening of Patient-Derived Organoids
Using High-Content Imaging
November
September
November
Cancer Organoid Screening: Bridging Reproducibility and Clinical Relevance in Drug Discovery
December
September
November
Cancer Research's Next Big Thing: A Deep Dive into Organoid Screening
Crown Bioscience Organoid Basics
Organoids V Spheroids: The 3D Difference Matters!
Defining Organoids: Exploring Their True Characteristics and Practical Uses
Organoids V Spheroids: The 3D Difference Matters!
By providing more physiologically relevant models, 3D cell cultures can bridge the gap between in vitro and in vivo models. Despite several options for 3D in vitro systems, the choice is not always straightforward. It largely depends on the biological question/s. This blog post examines key differences between spheroid and organoid models, so that you can make the best choice for your specific needs.
Crown Bioscience Biobank
Defining Organoids: Exploring Their True Characteristics and Practical Uses
Organoids V Spheroids: The 3D Difference Matters!
Our biobank offers over 200 patient-derived organoid (PDO) models for six oncological indications. Additionally, we have patient-matched normal models available for four indications, as well as patient-matched primary and metastatic models. Furthermore, we provide irritable bowel disease (IBD) PDO models for testing anti-inflammatory treatments and regenerative medicine approaches
Defining Organoids: Exploring Their True Characteristics and Practical Uses
Defining Organoids: Exploring Their True Characteristics and Practical Uses
Defining Organoids: Exploring Their True Characteristics and Practical Uses
The use of more clinically relevant preclinical models can help to reduce anticancer drug attrition rates by providing better understanding. This blog post explores the value of adult stem cell-derived 3D in vitro tumor organoids in drug discovery, particularly in identifying anticancer agents with improved translational potential, as highlighted in recent peer-reviewed publications.
Replay September's webinar now!
Matched Model Pairs and Patient-Derived Xenografts and Organoids Biobanks.
Don't miss this exclusive opportunity to gain invaluable insights from one of the authors of our pioneering publication on cancer pharmacology; learn about the transformative potential of a living biobank with over 550 matched pairs of patient-derived xenografts and organoids, and how it is revolutionizing approaches in high-throughput screening, immune therapies, imaging, and overcoming limitations in traditional drug development models.
Unmissable Webinars on Organoids, Interviews, Case Studies and Cutting-Edge Research!
From Crown Bioscience & World Organoid Research Day+ 2024
Watch Now and Win the chance of a free pair of tickets to
World Organoid Research Day+ in 2024!
Join us 27-28th February 2024 for World Organoid Research Day+
World Organoid Research Day+
In person. Cambridge, U.K
Organoid and Organ-on-a-chip talks on both days. WORD+ tickets fund research & research ticket attendees could win £1000 for their lab too.